Scientists at Invictus Oncology Pvt. Ltd. have utilized a novel linker chemistry to generate antibody-drug conjugates which act like “magic bullets,” a concept proposed by Nobel laureate, Paul Ehrlich. The technology can provide a targeted therapy to cancer patients whereby the antibody can home into specific markers or “addresses” expressed by cancer cells to deliver extremely toxic…